Global Polio (Poliomyelitis) Vaccines Market Insights, Forecast to 2029
This report presents an overview of global market for Polio (Poliomyelitis) Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Polio (Poliomyelitis) Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Polio (Poliomyelitis) Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Polio (Poliomyelitis) Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Polio (Poliomyelitis) Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Polio (Poliomyelitis) Vaccines sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Polio (Poliomyelitis) Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Polio (Poliomyelitis) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polio (Poliomyelitis) Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
This report researches the key producers of Polio (Poliomyelitis) Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Polio (Poliomyelitis) Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Polio (Poliomyelitis) Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Polio (Poliomyelitis) Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Polio (Poliomyelitis) Vaccines sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc.
By Company
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- Inactivated Polio Vaccine (IPV)
- Oral Polio Vaccine (OPV)
- Research & Academic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Polio (Poliomyelitis) Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Polio (Poliomyelitis) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polio (Poliomyelitis) Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 Polio (Poliomyelitis) Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market by Application
1.3.1 Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Polio (Poliomyelitis) Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global Polio (Poliomyelitis) Vaccines Revenue by Region
2.2.1 Global Polio (Poliomyelitis) Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Polio (Poliomyelitis) Vaccines Revenue by Region (2018-2023)
2.2.3 Global Polio (Poliomyelitis) Vaccines Revenue by Region (2024-2029)
2.2.4 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2018-2029)
2.3 Global Polio (Poliomyelitis) Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global Polio (Poliomyelitis) Vaccines Sales by Region
2.4.1 Global Polio (Poliomyelitis) Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Polio (Poliomyelitis) Vaccines Sales by Region (2018-2023)
2.4.3 Global Polio (Poliomyelitis) Vaccines Sales by Region (2024-2029)
2.4.4 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Polio (Poliomyelitis) Vaccines Sales by Manufacturers
3.1.1 Global Polio (Poliomyelitis) Vaccines Sales by Manufacturers (2018-2023)
3.1.2 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Polio (Poliomyelitis) Vaccines in 2022
3.2 Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturers
3.2.1 Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturers (2018-2023)
3.2.2 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Polio (Poliomyelitis) Vaccines Revenue in 2022
3.3 Global Key Players of Polio (Poliomyelitis) Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Polio (Poliomyelitis) Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Polio (Poliomyelitis) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Polio (Poliomyelitis) Vaccines Sales by Type
4.1.1 Global Polio (Poliomyelitis) Vaccines Historical Sales by Type (2018-2023)
4.1.2 Global Polio (Poliomyelitis) Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Polio (Poliomyelitis) Vaccines Revenue by Type
4.2.1 Global Polio (Poliomyelitis) Vaccines Historical Revenue by Type (2018-2023)
4.2.2 Global Polio (Poliomyelitis) Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Polio (Poliomyelitis) Vaccines Price by Type
4.3.1 Global Polio (Poliomyelitis) Vaccines Price by Type (2018-2023)
4.3.2 Global Polio (Poliomyelitis) Vaccines Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Polio (Poliomyelitis) Vaccines Sales by Application
5.1.1 Global Polio (Poliomyelitis) Vaccines Historical Sales by Application (2018-2023)
5.1.2 Global Polio (Poliomyelitis) Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Polio (Poliomyelitis) Vaccines Revenue by Application
5.2.1 Global Polio (Poliomyelitis) Vaccines Historical Revenue by Application (2018-2023)
5.2.2 Global Polio (Poliomyelitis) Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Polio (Poliomyelitis) Vaccines Price by Application
5.3.1 Global Polio (Poliomyelitis) Vaccines Price by Application (2018-2023)
5.3.2 Global Polio (Poliomyelitis) Vaccines Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Polio (Poliomyelitis) Vaccines Market Size by Type
6.1.1 US & Canada Polio (Poliomyelitis) Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2029)
6.2 US & Canada Polio (Poliomyelitis) Vaccines Market Size by Application
6.2.1 US & Canada Polio (Poliomyelitis) Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2029)
6.3 US & Canada Polio (Poliomyelitis) Vaccines Market Size by Country
6.3.1 US & Canada Polio (Poliomyelitis) Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Polio (Poliomyelitis) Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada Polio (Poliomyelitis) Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Polio (Poliomyelitis) Vaccines Market Size by Type
7.1.1 Europe Polio (Poliomyelitis) Vaccines Sales by Type (2018-2029)
7.1.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2029)
7.2 Europe Polio (Poliomyelitis) Vaccines Market Size by Application
7.2.1 Europe Polio (Poliomyelitis) Vaccines Sales by Application (2018-2029)
7.2.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2029)
7.3 Europe Polio (Poliomyelitis) Vaccines Market Size by Country
7.3.1 Europe Polio (Poliomyelitis) Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Polio (Poliomyelitis) Vaccines Sales by Country (2018-2029)
7.3.3 Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Polio (Poliomyelitis) Vaccines Market Size
8.1.1 China Polio (Poliomyelitis) Vaccines Sales (2018-2029)
8.1.2 China Polio (Poliomyelitis) Vaccines Revenue (2018-2029)
8.2 China Polio (Poliomyelitis) Vaccines Market Size by Application
8.2.1 China Polio (Poliomyelitis) Vaccines Sales by Application (2018-2029)
8.2.2 China Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Polio (Poliomyelitis) Vaccines Market Size by Type
9.1.1 Asia Polio (Poliomyelitis) Vaccines Sales by Type (2018-2029)
9.1.2 Asia Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2029)
9.2 Asia Polio (Poliomyelitis) Vaccines Market Size by Application
9.2.1 Asia Polio (Poliomyelitis) Vaccines Sales by Application (2018-2029)
9.2.2 Asia Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2029)
9.3 Asia Polio (Poliomyelitis) Vaccines Sales by Region
9.3.1 Asia Polio (Poliomyelitis) Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Polio (Poliomyelitis) Vaccines Revenue by Region (2018-2029)
9.3.3 Asia Polio (Poliomyelitis) Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Sanofi Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 GSK Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Company Information
11.3.2 Bibcol Overview
11.3.3 Bibcol Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Bibcol Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Company Information
11.4.2 Serum Institute Overview
11.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Serum Institute Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Company Information
11.5.2 Tiantan Biological Overview
11.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Tiantan Biological Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tiantan Biological Recent Developments
11.6 IMBCA
11.6.1 IMBCA Company Information
11.6.2 IMBCA Overview
11.6.3 IMBCA Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 IMBCA Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 IMBCA Recent Developments
11.7 Panacea Biotec Ltd
11.7.1 Panacea Biotec Ltd Company Information
11.7.2 Panacea Biotec Ltd Overview
11.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Panacea Biotec Ltd Recent Developments
11.8 Bio-Med
11.8.1 Bio-Med Company Information
11.8.2 Bio-Med Overview
11.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bio-Med Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bio-Med Recent Developments
11.9 Halfkin Bio-Pharmaceuticals
11.9.1 Halfkin Bio-Pharmaceuticals Company Information
11.9.2 Halfkin Bio-Pharmaceuticals Overview
11.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Polio (Poliomyelitis) Vaccines Industry Chain Analysis
12.2 Polio (Poliomyelitis) Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polio (Poliomyelitis) Vaccines Production Mode & Process
12.4 Polio (Poliomyelitis) Vaccines Sales and Marketing
12.4.1 Polio (Poliomyelitis) Vaccines Sales Channels
12.4.2 Polio (Poliomyelitis) Vaccines Distributors
12.5 Polio (Poliomyelitis) Vaccines Customers
13 MARKET DYNAMICS
13.1 Polio (Poliomyelitis) Vaccines Industry Trends
13.2 Polio (Poliomyelitis) Vaccines Market Drivers
13.3 Polio (Poliomyelitis) Vaccines Market Challenges
13.4 Polio (Poliomyelitis) Vaccines Market Restraints
14 KEY FINDINGS IN THE GLOBAL POLIO (POLIOMYELITIS) VACCINES STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Polio (Poliomyelitis) Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market by Application
1.3.1 Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Polio (Poliomyelitis) Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global Polio (Poliomyelitis) Vaccines Revenue by Region
2.2.1 Global Polio (Poliomyelitis) Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Polio (Poliomyelitis) Vaccines Revenue by Region (2018-2023)
2.2.3 Global Polio (Poliomyelitis) Vaccines Revenue by Region (2024-2029)
2.2.4 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2018-2029)
2.3 Global Polio (Poliomyelitis) Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global Polio (Poliomyelitis) Vaccines Sales by Region
2.4.1 Global Polio (Poliomyelitis) Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Polio (Poliomyelitis) Vaccines Sales by Region (2018-2023)
2.4.3 Global Polio (Poliomyelitis) Vaccines Sales by Region (2024-2029)
2.4.4 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Polio (Poliomyelitis) Vaccines Sales by Manufacturers
3.1.1 Global Polio (Poliomyelitis) Vaccines Sales by Manufacturers (2018-2023)
3.1.2 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Polio (Poliomyelitis) Vaccines in 2022
3.2 Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturers
3.2.1 Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturers (2018-2023)
3.2.2 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Polio (Poliomyelitis) Vaccines Revenue in 2022
3.3 Global Key Players of Polio (Poliomyelitis) Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Polio (Poliomyelitis) Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Polio (Poliomyelitis) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Polio (Poliomyelitis) Vaccines Sales by Type
4.1.1 Global Polio (Poliomyelitis) Vaccines Historical Sales by Type (2018-2023)
4.1.2 Global Polio (Poliomyelitis) Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Polio (Poliomyelitis) Vaccines Revenue by Type
4.2.1 Global Polio (Poliomyelitis) Vaccines Historical Revenue by Type (2018-2023)
4.2.2 Global Polio (Poliomyelitis) Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Polio (Poliomyelitis) Vaccines Price by Type
4.3.1 Global Polio (Poliomyelitis) Vaccines Price by Type (2018-2023)
4.3.2 Global Polio (Poliomyelitis) Vaccines Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Polio (Poliomyelitis) Vaccines Sales by Application
5.1.1 Global Polio (Poliomyelitis) Vaccines Historical Sales by Application (2018-2023)
5.1.2 Global Polio (Poliomyelitis) Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Polio (Poliomyelitis) Vaccines Revenue by Application
5.2.1 Global Polio (Poliomyelitis) Vaccines Historical Revenue by Application (2018-2023)
5.2.2 Global Polio (Poliomyelitis) Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Polio (Poliomyelitis) Vaccines Price by Application
5.3.1 Global Polio (Poliomyelitis) Vaccines Price by Application (2018-2023)
5.3.2 Global Polio (Poliomyelitis) Vaccines Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Polio (Poliomyelitis) Vaccines Market Size by Type
6.1.1 US & Canada Polio (Poliomyelitis) Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2029)
6.2 US & Canada Polio (Poliomyelitis) Vaccines Market Size by Application
6.2.1 US & Canada Polio (Poliomyelitis) Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2029)
6.3 US & Canada Polio (Poliomyelitis) Vaccines Market Size by Country
6.3.1 US & Canada Polio (Poliomyelitis) Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Polio (Poliomyelitis) Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada Polio (Poliomyelitis) Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Polio (Poliomyelitis) Vaccines Market Size by Type
7.1.1 Europe Polio (Poliomyelitis) Vaccines Sales by Type (2018-2029)
7.1.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2029)
7.2 Europe Polio (Poliomyelitis) Vaccines Market Size by Application
7.2.1 Europe Polio (Poliomyelitis) Vaccines Sales by Application (2018-2029)
7.2.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2029)
7.3 Europe Polio (Poliomyelitis) Vaccines Market Size by Country
7.3.1 Europe Polio (Poliomyelitis) Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Polio (Poliomyelitis) Vaccines Sales by Country (2018-2029)
7.3.3 Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Polio (Poliomyelitis) Vaccines Market Size
8.1.1 China Polio (Poliomyelitis) Vaccines Sales (2018-2029)
8.1.2 China Polio (Poliomyelitis) Vaccines Revenue (2018-2029)
8.2 China Polio (Poliomyelitis) Vaccines Market Size by Application
8.2.1 China Polio (Poliomyelitis) Vaccines Sales by Application (2018-2029)
8.2.2 China Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Polio (Poliomyelitis) Vaccines Market Size by Type
9.1.1 Asia Polio (Poliomyelitis) Vaccines Sales by Type (2018-2029)
9.1.2 Asia Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2029)
9.2 Asia Polio (Poliomyelitis) Vaccines Market Size by Application
9.2.1 Asia Polio (Poliomyelitis) Vaccines Sales by Application (2018-2029)
9.2.2 Asia Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2029)
9.3 Asia Polio (Poliomyelitis) Vaccines Sales by Region
9.3.1 Asia Polio (Poliomyelitis) Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Polio (Poliomyelitis) Vaccines Revenue by Region (2018-2029)
9.3.3 Asia Polio (Poliomyelitis) Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Sanofi Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 GSK Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Company Information
11.3.2 Bibcol Overview
11.3.3 Bibcol Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Bibcol Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Company Information
11.4.2 Serum Institute Overview
11.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Serum Institute Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Company Information
11.5.2 Tiantan Biological Overview
11.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Tiantan Biological Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tiantan Biological Recent Developments
11.6 IMBCA
11.6.1 IMBCA Company Information
11.6.2 IMBCA Overview
11.6.3 IMBCA Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 IMBCA Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 IMBCA Recent Developments
11.7 Panacea Biotec Ltd
11.7.1 Panacea Biotec Ltd Company Information
11.7.2 Panacea Biotec Ltd Overview
11.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Panacea Biotec Ltd Recent Developments
11.8 Bio-Med
11.8.1 Bio-Med Company Information
11.8.2 Bio-Med Overview
11.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bio-Med Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bio-Med Recent Developments
11.9 Halfkin Bio-Pharmaceuticals
11.9.1 Halfkin Bio-Pharmaceuticals Company Information
11.9.2 Halfkin Bio-Pharmaceuticals Overview
11.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Polio (Poliomyelitis) Vaccines Industry Chain Analysis
12.2 Polio (Poliomyelitis) Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polio (Poliomyelitis) Vaccines Production Mode & Process
12.4 Polio (Poliomyelitis) Vaccines Sales and Marketing
12.4.1 Polio (Poliomyelitis) Vaccines Sales Channels
12.4.2 Polio (Poliomyelitis) Vaccines Distributors
12.5 Polio (Poliomyelitis) Vaccines Customers
13 MARKET DYNAMICS
13.1 Polio (Poliomyelitis) Vaccines Industry Trends
13.2 Polio (Poliomyelitis) Vaccines Market Drivers
13.3 Polio (Poliomyelitis) Vaccines Market Challenges
13.4 Polio (Poliomyelitis) Vaccines Market Restraints
14 KEY FINDINGS IN THE GLOBAL POLIO (POLIOMYELITIS) VACCINES STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Inactivated Polio Vaccine (IPV)
Table 3. Major Manufacturers of Oral Polio Vaccine (OPV)
Table 4. Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Polio (Poliomyelitis) Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Polio (Poliomyelitis) Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Polio (Poliomyelitis) Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2018-2023)
Table 9. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2024-2029)
Table 10. Global Polio (Poliomyelitis) Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Polio (Poliomyelitis) Vaccines Sales by Region (2018-2023) & (K Units)
Table 12. Global Polio (Poliomyelitis) Vaccines Sales by Region (2024-2029) & (K Units)
Table 13. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2018-2023)
Table 14. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2024-2029)
Table 15. Global Polio (Poliomyelitis) Vaccines Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Polio (Poliomyelitis) Vaccines Sales Share by Manufacturers (2018-2023)
Table 17. Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Polio (Poliomyelitis) Vaccines Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Polio (Poliomyelitis) Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Polio (Poliomyelitis) Vaccines Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Polio (Poliomyelitis) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Polio (Poliomyelitis) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polio (Poliomyelitis) Vaccines as of 2022)
Table 23. Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
Table 28. Global Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
Table 29. Global Polio (Poliomyelitis) Vaccines Sales Share by Type (2018-2023)
Table 30. Global Polio (Poliomyelitis) Vaccines Sales Share by Type (2024-2029)
Table 31. Global Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Polio (Poliomyelitis) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Polio (Poliomyelitis) Vaccines Revenue Share by Type (2018-2023)
Table 34. Global Polio (Poliomyelitis) Vaccines Revenue Share by Type (2024-2029)
Table 35. Polio (Poliomyelitis) Vaccines Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Polio (Poliomyelitis) Vaccines Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
Table 38. Global Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
Table 39. Global Polio (Poliomyelitis) Vaccines Sales Share by Application (2018-2023)
Table 40. Global Polio (Poliomyelitis) Vaccines Sales Share by Application (2024-2029)
Table 41. Global Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Polio (Poliomyelitis) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Polio (Poliomyelitis) Vaccines Revenue Share by Application (2018-2023)
Table 44. Global Polio (Poliomyelitis) Vaccines Revenue Share by Application (2024-2029)
Table 45. Polio (Poliomyelitis) Vaccines Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Polio (Poliomyelitis) Vaccines Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Polio (Poliomyelitis) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Polio (Poliomyelitis) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Polio (Poliomyelitis) Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Polio (Poliomyelitis) Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Polio (Poliomyelitis) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (K Units)
Table 60. Europe Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
Table 61. Europe Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
Table 62. Europe Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Polio (Poliomyelitis) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
Table 65. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
Table 66. Europe Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Polio (Poliomyelitis) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Polio (Poliomyelitis) Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (K Units)
Table 72. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (K Units)
Table 73. China Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
Table 74. China Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
Table 75. China Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Polio (Poliomyelitis) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
Table 78. China Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
Table 79. China Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Polio (Poliomyelitis) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
Table 82. Asia Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
Table 83. Asia Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Polio (Poliomyelitis) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
Table 86. Asia Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
Table 87. Asia Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Polio (Poliomyelitis) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Polio (Poliomyelitis) Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Polio (Poliomyelitis) Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Polio (Poliomyelitis) Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Polio (Poliomyelitis) Vaccines Sales by Region (2018-2023) & (K Units)
Table 93. Asia Polio (Poliomyelitis) Vaccines Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (K Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Sanofi Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. GSK Company Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. GSK Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GSK Recent Developments
Table 117. Bibcol Company Information
Table 118. Bibcol Description and Major Businesses
Table 119. Bibcol Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Bibcol Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bibcol Recent Developments
Table 122. Serum Institute Company Information
Table 123. Serum Institute Description and Major Businesses
Table 124. Serum Institute Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Serum Institute Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Serum Institute Recent Developments
Table 127. Tiantan Biological Company Information
Table 128. Tiantan Biological Description and Major Businesses
Table 129. Tiantan Biological Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Tiantan Biological Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Tiantan Biological Recent Developments
Table 132. IMBCA Company Information
Table 133. IMBCA Description and Major Businesses
Table 134. IMBCA Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. IMBCA Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. IMBCA Recent Developments
Table 137. Panacea Biotec Ltd Company Information
Table 138. Panacea Biotec Ltd Description and Major Businesses
Table 139. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 140. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Panacea Biotec Ltd Recent Developments
Table 142. Bio-Med Company Information
Table 143. Bio-Med Description and Major Businesses
Table 144. Bio-Med Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 145. Bio-Med Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bio-Med Recent Developments
Table 147. Halfkin Bio-Pharmaceuticals Company Information
Table 148. Halfkin Bio-Pharmaceuticals Description and Major Businesses
Table 149. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 150. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Halfkin Bio-Pharmaceuticals Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Polio (Poliomyelitis) Vaccines Distributors List
Table 155. Polio (Poliomyelitis) Vaccines Customers List
Table 156. Polio (Poliomyelitis) Vaccines Market Trends
Table 157. Polio (Poliomyelitis) Vaccines Market Drivers
Table 158. Polio (Poliomyelitis) Vaccines Market Challenges
Table 159. Polio (Poliomyelitis) Vaccines Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
Table 1. Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Inactivated Polio Vaccine (IPV)
Table 3. Major Manufacturers of Oral Polio Vaccine (OPV)
Table 4. Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Polio (Poliomyelitis) Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Polio (Poliomyelitis) Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Polio (Poliomyelitis) Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2018-2023)
Table 9. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2024-2029)
Table 10. Global Polio (Poliomyelitis) Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Polio (Poliomyelitis) Vaccines Sales by Region (2018-2023) & (K Units)
Table 12. Global Polio (Poliomyelitis) Vaccines Sales by Region (2024-2029) & (K Units)
Table 13. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2018-2023)
Table 14. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2024-2029)
Table 15. Global Polio (Poliomyelitis) Vaccines Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Polio (Poliomyelitis) Vaccines Sales Share by Manufacturers (2018-2023)
Table 17. Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Polio (Poliomyelitis) Vaccines Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Polio (Poliomyelitis) Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Polio (Poliomyelitis) Vaccines Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Polio (Poliomyelitis) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Polio (Poliomyelitis) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polio (Poliomyelitis) Vaccines as of 2022)
Table 23. Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of Polio (Poliomyelitis) Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
Table 28. Global Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
Table 29. Global Polio (Poliomyelitis) Vaccines Sales Share by Type (2018-2023)
Table 30. Global Polio (Poliomyelitis) Vaccines Sales Share by Type (2024-2029)
Table 31. Global Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Polio (Poliomyelitis) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Polio (Poliomyelitis) Vaccines Revenue Share by Type (2018-2023)
Table 34. Global Polio (Poliomyelitis) Vaccines Revenue Share by Type (2024-2029)
Table 35. Polio (Poliomyelitis) Vaccines Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Polio (Poliomyelitis) Vaccines Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
Table 38. Global Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
Table 39. Global Polio (Poliomyelitis) Vaccines Sales Share by Application (2018-2023)
Table 40. Global Polio (Poliomyelitis) Vaccines Sales Share by Application (2024-2029)
Table 41. Global Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Polio (Poliomyelitis) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Polio (Poliomyelitis) Vaccines Revenue Share by Application (2018-2023)
Table 44. Global Polio (Poliomyelitis) Vaccines Revenue Share by Application (2024-2029)
Table 45. Polio (Poliomyelitis) Vaccines Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Polio (Poliomyelitis) Vaccines Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Polio (Poliomyelitis) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Polio (Poliomyelitis) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Polio (Poliomyelitis) Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Polio (Poliomyelitis) Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Polio (Poliomyelitis) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (K Units)
Table 60. Europe Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
Table 61. Europe Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
Table 62. Europe Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Polio (Poliomyelitis) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
Table 65. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
Table 66. Europe Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Polio (Poliomyelitis) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Polio (Poliomyelitis) Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (K Units)
Table 72. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (K Units)
Table 73. China Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
Table 74. China Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
Table 75. China Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Polio (Poliomyelitis) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
Table 78. China Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
Table 79. China Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Polio (Poliomyelitis) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
Table 82. Asia Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
Table 83. Asia Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Polio (Poliomyelitis) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
Table 86. Asia Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
Table 87. Asia Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Polio (Poliomyelitis) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Polio (Poliomyelitis) Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Polio (Poliomyelitis) Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Polio (Poliomyelitis) Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Polio (Poliomyelitis) Vaccines Sales by Region (2018-2023) & (K Units)
Table 93. Asia Polio (Poliomyelitis) Vaccines Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (K Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Sanofi Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. GSK Company Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. GSK Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GSK Recent Developments
Table 117. Bibcol Company Information
Table 118. Bibcol Description and Major Businesses
Table 119. Bibcol Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Bibcol Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bibcol Recent Developments
Table 122. Serum Institute Company Information
Table 123. Serum Institute Description and Major Businesses
Table 124. Serum Institute Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Serum Institute Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Serum Institute Recent Developments
Table 127. Tiantan Biological Company Information
Table 128. Tiantan Biological Description and Major Businesses
Table 129. Tiantan Biological Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Tiantan Biological Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Tiantan Biological Recent Developments
Table 132. IMBCA Company Information
Table 133. IMBCA Description and Major Businesses
Table 134. IMBCA Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. IMBCA Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. IMBCA Recent Developments
Table 137. Panacea Biotec Ltd Company Information
Table 138. Panacea Biotec Ltd Description and Major Businesses
Table 139. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 140. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Panacea Biotec Ltd Recent Developments
Table 142. Bio-Med Company Information
Table 143. Bio-Med Description and Major Businesses
Table 144. Bio-Med Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 145. Bio-Med Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bio-Med Recent Developments
Table 147. Halfkin Bio-Pharmaceuticals Company Information
Table 148. Halfkin Bio-Pharmaceuticals Description and Major Businesses
Table 149. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 150. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Halfkin Bio-Pharmaceuticals Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Polio (Poliomyelitis) Vaccines Distributors List
Table 155. Polio (Poliomyelitis) Vaccines Customers List
Table 156. Polio (Poliomyelitis) Vaccines Market Trends
Table 157. Polio (Poliomyelitis) Vaccines Market Drivers
Table 158. Polio (Poliomyelitis) Vaccines Market Challenges
Table 159. Polio (Poliomyelitis) Vaccines Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Polio (Poliomyelitis) Vaccines Product Picture
Figure 2. Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Polio (Poliomyelitis) Vaccines Market Share by Type in 2022 & 2029
Figure 4. Inactivated Polio Vaccine (IPV) Product Picture
Figure 5. Oral Polio Vaccine (OPV) Product Picture
Figure 6. Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Polio (Poliomyelitis) Vaccines Market Share by Application in 2022 & 2029
Figure 8. Research & Academic Laboratories
Figure 9. Pharmaceutical & Biotechnology Companies
Figure 10. Others
Figure 11. Polio (Poliomyelitis) Vaccines Report Years Considered
Figure 12. Global Polio (Poliomyelitis) Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Polio (Poliomyelitis) Vaccines Revenue 2018-2029 (US$ Million)
Figure 14. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2018-2029)
Figure 16. Global Polio (Poliomyelitis) Vaccines Sales 2018-2029 ((K Units)
Figure 17. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Polio (Poliomyelitis) Vaccines Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Polio (Poliomyelitis) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Polio (Poliomyelitis) Vaccines Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Polio (Poliomyelitis) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Polio (Poliomyelitis) Vaccines Sales YoY (2018-2029) & (K Units)
Figure 23. China Polio (Poliomyelitis) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Polio (Poliomyelitis) Vaccines Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Polio (Poliomyelitis) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Polio (Poliomyelitis) Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Polio (Poliomyelitis) Vaccines in the World: Market Share by Polio (Poliomyelitis) Vaccines Revenue in 2022
Figure 30. Global Polio (Poliomyelitis) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
Figure 32. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
Figure 33. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
Figure 34. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Polio (Poliomyelitis) Vaccines Revenue Share by Country (2018-2029)
Figure 40. US & Canada Polio (Poliomyelitis) Vaccines Sales Share by Country (2018-2029)
Figure 41. U.S. Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
Figure 44. Europe Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
Figure 45. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
Figure 46. Europe Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
Figure 47. Europe Polio (Poliomyelitis) Vaccines Revenue Share by Country (2018-2029)
Figure 48. Europe Polio (Poliomyelitis) Vaccines Sales Share by Country (2018-2029)
Figure 49. Germany Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 50. France Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 54. China Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
Figure 55. China Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
Figure 56. China Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
Figure 57. China Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
Figure 58. Asia Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
Figure 59. Asia Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
Figure 60. Asia Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
Figure 61. Asia Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
Figure 62. Asia Polio (Poliomyelitis) Vaccines Revenue Share by Region (2018-2029)
Figure 63. Asia Polio (Poliomyelitis) Vaccines Sales Share by Region (2018-2029)
Figure 64. Japan Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 68. India Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales Share by Country (2018-2029)
Figure 75. Brazil Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 80. Polio (Poliomyelitis) Vaccines Value Chain
Figure 81. Polio (Poliomyelitis) Vaccines Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Figure 1. Polio (Poliomyelitis) Vaccines Product Picture
Figure 2. Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Polio (Poliomyelitis) Vaccines Market Share by Type in 2022 & 2029
Figure 4. Inactivated Polio Vaccine (IPV) Product Picture
Figure 5. Oral Polio Vaccine (OPV) Product Picture
Figure 6. Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Polio (Poliomyelitis) Vaccines Market Share by Application in 2022 & 2029
Figure 8. Research & Academic Laboratories
Figure 9. Pharmaceutical & Biotechnology Companies
Figure 10. Others
Figure 11. Polio (Poliomyelitis) Vaccines Report Years Considered
Figure 12. Global Polio (Poliomyelitis) Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Polio (Poliomyelitis) Vaccines Revenue 2018-2029 (US$ Million)
Figure 14. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2018-2029)
Figure 16. Global Polio (Poliomyelitis) Vaccines Sales 2018-2029 ((K Units)
Figure 17. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Polio (Poliomyelitis) Vaccines Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Polio (Poliomyelitis) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Polio (Poliomyelitis) Vaccines Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Polio (Poliomyelitis) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Polio (Poliomyelitis) Vaccines Sales YoY (2018-2029) & (K Units)
Figure 23. China Polio (Poliomyelitis) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Polio (Poliomyelitis) Vaccines Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Polio (Poliomyelitis) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Polio (Poliomyelitis) Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Polio (Poliomyelitis) Vaccines in the World: Market Share by Polio (Poliomyelitis) Vaccines Revenue in 2022
Figure 30. Global Polio (Poliomyelitis) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
Figure 32. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
Figure 33. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
Figure 34. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Polio (Poliomyelitis) Vaccines Revenue Share by Country (2018-2029)
Figure 40. US & Canada Polio (Poliomyelitis) Vaccines Sales Share by Country (2018-2029)
Figure 41. U.S. Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
Figure 44. Europe Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
Figure 45. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
Figure 46. Europe Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
Figure 47. Europe Polio (Poliomyelitis) Vaccines Revenue Share by Country (2018-2029)
Figure 48. Europe Polio (Poliomyelitis) Vaccines Sales Share by Country (2018-2029)
Figure 49. Germany Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 50. France Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 54. China Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
Figure 55. China Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
Figure 56. China Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
Figure 57. China Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
Figure 58. Asia Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
Figure 59. Asia Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
Figure 60. Asia Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
Figure 61. Asia Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
Figure 62. Asia Polio (Poliomyelitis) Vaccines Revenue Share by Region (2018-2029)
Figure 63. Asia Polio (Poliomyelitis) Vaccines Sales Share by Region (2018-2029)
Figure 64. Japan Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 68. India Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Polio (Poliomyelitis) Vaccines Sales Share by Country (2018-2029)
Figure 75. Brazil Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Polio (Poliomyelitis) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 80. Polio (Poliomyelitis) Vaccines Value Chain
Figure 81. Polio (Poliomyelitis) Vaccines Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
